[Deep brain stimulation in movement disorders: a Prague-center experience]
Dusan Urgosík1, Robert Jech, Evzen Růzicka
1Oddelení stereotaktická a radiacní neurochirurgie Nemocnice Na Homolce, Praha. dusan.urgosik@homolka.cz
Casopis Lekaru Ceskych
|June 4, 2011
Summary
Deep brain stimulation (DBS) effectively treats Parkinson's disease, essential tremor, and dystonia by targeting specific brain areas. This study shows high success rates in reducing symptoms like rigidity, tremor, and dyskinesias with minimal complications.
Area of Science:
- Neurology
- Neurosurgery
Context:
- Deep brain stimulation (DBS) is a crucial therapy for movement disorders.
- Electrodes target key basal ganglia structures like the subthalamic nucleus (STN), internal globus pallidus (GPi), and ventral intermediate nucleus (VIM).
Purpose:
- To evaluate the efficacy and safety of DBS in treating Parkinson's disease (PD), essential tremor (ET), and dystonia.
- To report outcomes from a large patient cohort at the Center for Movement Disorders in Prague.
Summary:
- DBS was performed on 127 patients: 86 with PD, 19 with dystonia, and 22 with tremor.
- Intraoperative success rates included eliminating rigidity in 95% of PD cases and tremor in 93% of ET cases.
- Dystonia symptom improvement occurred in 95% of patients within weeks, with overall low complication rates (8% transient morbidity, 1% hemorrhage, 6% infection, 7% hardware issues).
Impact:
- DBS offers significant symptom relief for debilitating movement disorders.
- The study demonstrates the clinical effectiveness and manageable safety profile of DBS in a substantial patient group.
- Findings support DBS as a valuable treatment option for selected patients with PD, ET, and dystonia.
More Related Videos
07:14A Novel Approach to Assess Motor Outcome of Deep Brain Stimulation Effects in the Hemiparkinsonian Rat: Staircase and Cylinder Test
Published on: May 31, 2016
14:14Targeting Neuronal Fiber Tracts for Deep Brain Stimulation Therapy Using Interactive, Patient-Specific Models
Published on: August 12, 2018
